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ABSTRACT
Objective: The aim of this paper is to identify the list of microRNA (miRNA) which can regulate the aberrant expression of IQGAP in liver cancer 
formation. The aberrant expression of IQ motif-containing GTPase-activating protein (IQGAP) family which consists of IQGAP1, IQGAP2, and IQGAP3 
has been linked to carcinogenesis in human cancers. The reciprocal expression of IQGAP family in human cancer has been studied to act as oncogenes 
or tumor suppressor genes. A growing number of studies suggest that upregulated or downregulated expression of IQGAP family triggers cancer 
development.
Methods: A correlation study was performed to construct a pathway to inhibit or activate IQGAP family between miRNAs and IQGAPs. A pre-
processing step was conducted to download, filter and process the dataset from TCGA. It yields miRNA and IQGAP gene expression matrix. Then, 
correlation computation was computed using MATLAB. Moreover, this study linked the results to the MiRTarBase to validate the prediction result 
with the wet lab experimental result.
Results: This study identified significantly inversely correlation in 51 miRNAs-IQGAP1, 169 miRNAs-IQGAP2, and 33 miRNAs-IQGAP3, respectively, 
which may potentially play a role in a liver cancer formation. Some of the results also can be found in miRTarBase. It supports the precision of those 
miRNA and IQGAP interaction between dry lab and wet lab study. IQGAP1 and IQGAP2 mostly has been identified as an oncogene in cancer but IQGAP2 
has been discovered as tumor suppressor gene. The list of miRNA in the result of this study can become a potential therapy to target the aberrant 
expression of IQGAP family. 
Conclusion: miRNA function is known as an oncogene or tumor suppressor gene in cancer development. Therefore, it can be one of the important 
molecular biology which may target the aberrant expression of IQGAP in liver cancer.
Keywords: MicroRNA; miRNA; Oncogene; Tumor suppressor gene, IQGAP1, IQGAP2, IQGAP3, Liver cancer, Cancer.
INTRODUCTION
Hepatocellular carcinoma (HCC) is the most common type of liver 
cancer, which accounts for 83% of all cases [1]. Moreover, HCC ranks 
fourth among cancer-related mortality in Indonesia; it is 3 times higher 
in males than females [2]. Among all the causes, chronic infection by 
hepatitis B virus or hepatitis C virus, aflatoxin B1 exposure, and excessive 
alcohol consumption is one of the most prominent predisposing factors 
that may lead to hepatocarcinogenesis [1,3]. Therapeutic regimens for 
HCC include chemotherapy, surgery, and radiation therapy. However, 
the increasing evidence of cancer chemoresistance raise an urgency 
to develop novel molecular-targeted therapy which is essential as an 
addition to therapeutic modalities of HCC.
IQ-domain GTPase-activating proteins (IQGAPs) are a family of 
multidomain proteins that are found in various eukaryotes from yeast 
to mammals and regulate cellular physiology including cell adhesion, 
cell migration, extracellular signals, and cytokinesis [4-6]. There 
are three IQGAPs in human: IQGAP1, IQGAP2, and IQGAP3; the first 
mentioned is the most well characterized [6,7]. Many studies have 
been reported the involvement of IQGAPs in human cancers, including 
gastric [8], pancreatic [9], ovarian [10], esophageal [11], colorectal, and 
prostate cancer [12]. Interestingly, several studies reported a distinct 
role between all of three IQGAPs. While IQGAP1 and IQGAP3 have been 
reported to promote tumorigenesis, IQGAP2 was found to have tumor-
suppressing ability [6,13]. Therefore, investigating the inhibition 
mechanism of IQGAP1 or enhancing the expression of IQGAP2 might 
be necessary to discover their therapeutic potentials. In human, HCC, 
positive IQGAP1, and negative IQGAP2 expression were linked to tumor 
progression and might determine clinical outcomes [12]. Moreover, 
IQGAP3 has been also reported in various cancers. Its expression is 
overexpressed in several tumor tissues and significantly increased 
in pancreatic cancer tissues, compared with non-cancerous tissues. 
Knocking down of IQGAP3 in two pancreatic cancer cell lines with a 
high level of IQGAP3 significantly inhibited cell proliferation, migration, 
and invasion and induced cell apoptosis [14]. The aberrant expression 
of IQGAP family can also be identified in some other cancer types such 
as IQGAP1 which increases RhoA/C GTP loading and is required for 
RhoA/C-induced proliferation and motility of breast cancer cells [15]. 
IQGAP1 and CDC42 are widely upregulated in human glioma tissues, 
and their expression levels have a positive correlation with tumor 
malignancy [16]. IQGAP1, as well as E-cadherin, plays a role in gastric 
carcinogenesis [17]. Knockdown of IQGAP1 inhibited the proliferation 
of thyroid cancer cells, EMT, and the Wnt/β-catenin pathway 
expression [18]. IQGAP2 was mostly downregulated in different cancer 
types such as breast, lung, gastric, colorectal, liver, and kidney. On 
the other hand, IQGAP3 was consistently upregulated across most of 
the cancer types including the breast, lung, gastric, colorectal, brain, 
prostate, liver, and kidney. The expression pattern of these two IQGAP 
isoforms across different cancer types supports the notion that IQGAP2 
possibly plays the role of a tumor suppressor gene (TSG), whereas 
IQGAP3 is more likely to be an oncogene. It is supported by various 
literature [19]. SUMOylation on IQGAP1 affects the development 
of colorectal cancer [20], and IQGAP1 promotes CRC cell growth, 
migration, and tumorigenesis by activating the phosphorylation of ERK, 
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MEK, and AKT. The mechanism of SUMOylation in IQGAP1, especially 
its binding sites, is still unclear and requires more study and better 
methods to yield absolute results. Preventing SUMOylation on IQGAP1 
may be a possible novel treatment for colorectal cancer. However, the 
concerning study about miRNA targeting IQGAPs in cancer are still 
lacking.
miRNA is a small non-coding RNA that regulate two-third of the 
entire protein-coding genome and function by sequence specific 
binding to 3’ end of untranslated region of a target mRNA to inhibit 
its expression [21]. miRNA can function as oncogenes (OCG) or TSG.
In this research, we performed a correlation study between miRNA and 
IQGAPs gene expression to establish the potential miRNAs-regulated 
pathways in liver cancer formation. Moreover, we also linked the results 
to the miRTarBase database to identify whether our results have a Wet 
Lab validation result.
METHODOLOGY
Our method aim is to evaluate miRNA-regulated IQGAPs which cause 
liver cancer. We identified a set of potential importance miRNAs 
and genes based on their expression RNA-Seq data. The samples are 
available from The Cancer Genome Atlas (TCGA) repository January 
2018 version. We used the level 3 data from TCGA and filtered out the 
healthy samples and considered only tumor samples. The level 3 data 
represent the expression of particular genes/miRNAs per sample. Level 
3 data were derived from the raw signals per probe (level 1), were 
normalized per probe set (level 2), and then averaged for a gene.
To investigate the miRNA-regulated IQGAPs mechanism, this study 
integrated gene, miRNA expression data, and experimentally miRNA-
gene interaction. miRNA and gene expression were collected from TCGA, 
and the information about miRNA also was retrieved from the miRbase 
database. Experimentally, miRNA-genes interaction data were collected 
from the miRTarBase database, which collects experimental data for 
miRNA targets. Then, a correlation study was performed where the 
above-mentioned data sources were imported and integrated. Table 1 
summarized the resources of the database adopted for the present study.
Table 1: Databases resources adopted for the present study
Database General Information provided
miRTarBase Experimentally tested miRNA target genes
miRbase Information of miRNA
TCGA miRNA and gene expression RNASeq data
Pre-processing step
In a pre-processing step, this study constructs the miRNA expression 
matrix and IQGAP expression matrix using the same set of patients. The 
order of the sample/patient expression in miRNA and IQGAPs in each 
file is the same. For example, a patient/sample of miRNA expression 
is put in the second column of miRNA expression matrix file, then 
the same patient/sample of gene expression is also put in the second 
column of gene expression matrix file. Therefore, if we have 165 patient 
gene expressions, we will also have 165 patient miRNA expressions in 
the different files.
Computational analysis
This study computed a Spearman rank correlation coefficient between 
IQGAPS families which are IQGAP1, IQGAP2, and IQGAP3 with 1,881 
miRNAs in 165 liver HCC cancer samples. In total, there are 5,643 
correlations. The computation was performed using MATLAB. The 
MATLAB program of Spearman computation yields a correlation score 
and p-value between all genes and miRNAs in the gene expression 
file and miRNA expression file. As a result, this study obtained a file 
with 5,643 miRNA-gene correlation result where each result returned 
the Spearman correlation with the p-value of that correlation. The 
Spearman correlation value is between ± 0 and 1. A positive correlation 
means that gene and miRNA expression have a positive relationship 
between them (if miRNA expression is high, then the gene expression 
is high and vice versa) and negative correlation means that gene and 
miRNA expression have a negative relationship where if a miRNA 
expression is high, then the gene expression is low and vice versa. The 
Spearman rank correlation coefficient analysis is selected instead of 
Pearson correlation because of the capability to handle the outlier.
Link to the experimental miRNA target genes miRTarBase
The list of potential miRNA-regulated IQGAPs was linked to the 
miRTarBase database to check whether there is an overlapping result 
between this study result and Wet Lab experimentally validated 
result. As a database, miRTarBase has accumulated more than 300 
and 60,000 miRNA-target interactions. The interactions are validated 
experimentally by reporter assay, western blot, qPCR, microarray, next-
generation sequencing experiments, and pSILAC [22]. The website can 
be accessed at http://mirtarbase.mbc.nctu.edu.tw/php/index.php. 
This study overlapped the list of potentially miRNA-regulated IQGAPs 
with the list of experimentally validated miRNA targeting IQGAP1, 
IQGAP2, and IQGAP3. The workflows of this study are depicted in Fig. 1.
Collect gene and miRNA expression RNASeq data
from TCGA database for liver cancer samples
Computation analysis using spearman rank correlation coefficient
Overlapping potential miRNA-regulated IQGAP genes in silico
study to the miRTarbase database experimentally validated
miRNA-target gene interactions result
Fig. 1: Workflow for the miRNA-regulated IQ motif-containing 
GTPase-activating proteins in liver cancer
RESULTS AND DISCUSSION
We identified miRNA-IQGAP-related genes significantly inversely 
correlated where Spearman rank correlation coefficient <−0.20 and 
p<0.05. The cutoff is based on our previous study [23]. The results are 
described in Tables 2-4. Moreover, this study found miR-128-1 and 
miR-4424 which significantly inversely correlated with IQGAP1 are also 
identified in miRTarBase. It suggests that two of our silico results are 
linked to the validated miRNA-gene interaction in miRTarBase and for the 
rest of the results are suggested to be validated by Wet Lab experiments.
52, 169, and 33 miRNAs in liver cancer significantly inversely correlated 
with IQGAP1, IQGAP2, and IQGAP3, respectively. It is noted that certain 
miRNA can have multiple targets, for example, in our correlation result, 
miR-122 and miR-148a negatively correlated with IQGAP1 and IQGAP3. 
These results suggest the list of potential miRNA which can regulate the 
aberrant expression of IQGAPs in liver cancer. Tables 2-4 are the top 
20 miRNAs which have a negatively significant correlation with IQGAP 
family. In Tables 2-4, miR-194-2, miR-3200, and miR-451a are the most 
significantly inversely correlated with IQGAP1, IQGAP2, and IQGAP3, 
respectively. The significant negative correlation can be the initial hint 
for this study to further analyze the causation effect between those 
listed negatively miRNA genes in Tables 2-4.
This study can contribute as a preliminary analysis to identify the role 
of miRNA in regulating IQGAPs. Mostly, previous study stated that the 
aberrant expression of IQGAP family especially IQGAP1 is linked to the 
tumor development in many type of cancers. However, the analysis on 
the treatment toward that aberrant expression of IQGAPs is still lack. 
Therefore, the results of this study can be used as an initial step to 
evaluate the role of miRNA in regulating IQGAPs.
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In summary, these findings suggest a two mechanism for cancer 
formation. In the first mechanism, aberrant IQGAP expression that 
functions as OCG is activated by miRNAs. The second mechanism 
aberrant IQGAPs expression that functions as TSG is inhibited by 
miRNAs. These two mechanisms are illustrated in Fig. 2. For example, 
it was found that IQGAP1 is possibly silenced by miR-194-2. If this 
miRNA targets an OCG, the result of activating IQGAP1 may lead to 
cancer formation. The bottom half of Fig. 2 illustrates the concept of an 
inhibiting TSG that plays a tumor suppressor role in cancer formation.
CONCLUSION
Our understanding of how miRNA changes affect the regulation of 
IQGAPs remains immature. An important contribution of the current 
study is to conduct genome-wide scale study of miRNAs regulation 
of IQGAPs, using liver cancer as an illustration. We integrated gene 
expression, miRNA, and target gene information to establish miRNA-
regulated pathways by looking for aberrant IQGAPs genes that 
targeted by miRNA. Then, we validated our computation result with 
the experimentally validated miRNA-gene interaction. This study can 
provide the list of potential miRNA that could target IQGAP1, IQGAP2, 
and IQGAP3 in liver cancer formation. This work demonstrated that 
IQGAPs could be activated/silenced by miRNA and involves in cancer 
formations. This platform provides an easy means of investigating 
miRNA-regulated IQGAPs in a cancer study.
In the future study, this present study will explore the TCGA datasets 
by including more cancer types, and also this study will perform the 
differentially express miRNA and also differentially express gene. 
Therefore, we need to include normal sample dataset in our analysis. 
When this study identifies which gene or miRNA has an aberrant 
expression in human cancer, then we will link the aberrant expression 
result with this present study result. TCGA also provides a filter by age, 
gender, and races. It is also possible to separate sample based on their 
age, gender, and race. In the future research, this study will have a better 
mechanism to construct a pathway to study IQGAPs in human cancers.
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Fig. 2: Two possible miRNA regulation mechanism of IQGAP 
pathways can lead to the liver cancer.
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